Ligand Pharmaceuticals Inc (NASDAQ:LGND)

67.55
Delayed Data
As of Mar 04
 +1.10 / +1.66%
Today’s Change
41.99
Today|||52-Week Range
80.21
+26.95%
Year-to-Date

Today’s Trading

Previous close66.45
Today’s open66.00
Day’s range65.40 - 68.69
Volume507,989
Average volume (3 months)289,627
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+41.94%
Earnings growth (next 5 years)+38.40%
Revenue growth (last year)+31.78%
P/E ratio120.6
Price/Sales16.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NLNKNewLink Genetics Cor...+3.39+7.35%
MACKMerrimack Pharmaceut...+0.06+0.51%
USNAUSANA Health Science...-0.96-0.95%
ACHNAchillion Pharmaceut...-0.51-4.20%
Data as of 4:14pm ET, 03/04/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$0.27
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President, Chief Operating Officer &
Director
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account